9th Complement-based Drug Development Summit

Topics

• Quantifying Complement Levels with Sensitive & Specific Assays
• Correlation Vs. Causation: Does Complement Drive Disease Pathology or is it a Biological Response?
• What is the Best Fragment to Target; Positioning Complement Inhibitors Against Complement Inhibitors
• Investigating Sensitive & Specific Assays to Quantify Complement Levels in Tissues
• Optimizing Clinical Development Strategies to Ensure Commercial Success with Complement Therapeutics
• Mitigating Toxicity Effects of Immunosuppression with Complement Inhibitors
• New Modalities of Complement Therapeutics Demonstrating Clinical Promise
• Exploring the Non-Canonical Functions of Complement & Identifying Future Therapeutic Opportunities